Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Novel orally active iron chelator presented by Novartis researchers

Oct. 21, 1998

Nicotinic acetylcholine receptor ligands from Pfizer for addictive and CNS disorders

Oct. 13, 1998

SmithKline Beecham to market smoking cessation patch in China

Oct. 6, 1998

SmithKline Beecham acquires transdermal nicotine product in Australia and New Zealand

Oct. 5, 1998

Caroverine shown to effective treatment for alcohol withdrawal syndrome

Sep. 22, 1998

Nicotine Inhaler launched nationwide in the U.S.

Sep. 11, 1998

Tropane analogues claimed for cocaine addiction by HHS

Sep. 9, 1998

Spotlight on treatment of substance abuse disorders

Sep. 4, 1998

DAT inhibitor RTI-113 prevents cocaine consumption by rats

Sep. 3, 1998

Lead candidate for botulinum neurotoxin poisoning: ICD-1578

Sep. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...